SCM
ARRY

Suffolk Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Suffolk Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-466,713
Closed -$2.13M – 163
2014
Q2 		$2.13M Sell
466,713
-12,400
-3% -$51.3K 0.26% 118
2014
Q1 		$2.25M Buy
479,113
+13,800
+3% +$69.4K 0.28% 117
2013
Q4 		$2.33M Buy
465,313
+96,200
+26% +$524K 0.29% 120
2013
Q3 		$2.3M Buy
369,113
+10,000
+3% +$59.4K 0.31% 113
2013
Q2 		$1.63M Buy
+359,113
New +$1.93M 0.23% 124

Other funds holding ARRY

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Suffolk Capital Management's ARRY Position: Q3 2014 in Review

Suffolk Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2014, closing a stake of 466,713 shares — an estimated $2.13M sold.

Suffolk Capital Management first reported a position in ARRY in Q2 2013 and held it in 5 quarters. The position peaked at $2.33M in Q4 2013. 112 funds tracked by Wall St. Rank hold ARRY as of Q3 2014.

  • Suffolk Capital Management reported no remaining Array Biopharma Inc position as of Q3 2014 after selling out during the quarter.
  • Suffolk Capital Management sold 466,713 Array Biopharma Inc shares in Q3 2014, an estimated $2.13M.
  • Suffolk Capital Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 5 quarters.
  • Suffolk Capital Management's Array Biopharma Inc position peaked at $2.33M in Q4 2013.
  • 112 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2014.

Based on Suffolk Capital Management's 13F filing for Q3 2014, filed 5 Nov 2014.